Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for reducing pain and anxiety during bone marrow sampling in patients with hematologic malignancies
IRCT20140818018842N48Phase 3Completed
- Sponsor
- Hematology, Oncology and Stem Cell Transplantation Research Center
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in hematopoietic malignancies, sponsored by Hematology, Oncology and Stem Cell Transplantation Research Center. Started Apr 2025; status: completed.
02
Drugs
melatonin
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on IRCT20140818018842N48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140818018842N48.